Dr. Margaret Lawson, MD
Claim this profileChildren's Hospital of Eastern Ontario
Studies Diabetes
Studies Type 1 Diabetes
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Margaret Lawson, MD is currently running
Hybrid Closed Loop System
for Type 1 Diabetes
The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)
Recruiting1 award N/A17 criteria
Rapid Vitamin D Supplementation
for Vitamin D Deficiency
Vitamin D plays an important role in calcium balance, heart and lung health, inflammation, infection prevention, and muscle strength. Due to these roles, it has been suggested that critically ill patients with low vitamin D levels might have higher rates of death and worse long-term health. We believe that identifying critically ill children with vitamin D deficiency and then restoring vitamin D levels quickly could represent a safe, easy and inexpensive means of reducing patient illness, preventing death and improving quality of life. This clinical trial will determine whether rapid normalization of vitamin D deficiency improves survival and health-related quality of life following critical illness. The VITdALIZE-KIDS trial is a multicentre randomized clinical trial in Canadian Pediatric Intensive Care Units (PICUs). Critically ill children who agree to participate (consent given by caregivers) will have their blood vitamin D level measured, and those who are vitamin D deficient will be randomized to receive a single dose of either high-dose vitamin D3 or placebo (no drug). Study participants assigned to the high-dose vitamin D arm will receive 10,000 IU/kg of enteral cholecalciferol (up to a maximum of 400,000 IU). We have tested this dose in a pilot trial, and no patient experienced serious adverse events related to vitamin D administration. Patients will be followed for 90 days to determine whether they survived and had a significant change in their health and quality of life. Vitamin D deficiency is a common problem not only among critically ill Canadian children, but in PICUs worldwide. In addition to being applicable in Canada, our study protocol was designed to be generalizable and meaningful to critically ill children worldwide.
Recruiting1 award Phase 3
More about Margaret Lawson, MD
Clinical Trial Related7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Margaret Lawson, MD has experience with
- Placebo
- Hydroxychloroquine
- 670G And 770G Insulin Pump
- Subject's Current Diabetes Therapy
- Cholecalciferol
Breakdown of trials Margaret Lawson, MD has run
Diabetes
Type 1 Diabetes
Vitamin D Deficiency
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret Lawson, MD specialize in?
Margaret Lawson, MD focuses on Diabetes and Type 1 Diabetes. In particular, much of their work with Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Margaret Lawson, MD currently recruiting for clinical trials?
Yes, Margaret Lawson, MD is currently recruiting for 2 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Margaret Lawson, MD has studied deeply?
Yes, Margaret Lawson, MD has studied treatments such as Placebo, Hydroxychloroquine, 670G and 770G Insulin Pump.
What is the best way to schedule an appointment with Margaret Lawson, MD?
Apply for one of the trials that Margaret Lawson, MD is conducting.
What is the office address of Margaret Lawson, MD?
The office of Margaret Lawson, MD is located at: Children's Hospital of Eastern Ontario, Ottawa, Ontario K1H8L1 Canada. This is the address for their practice at the Children's Hospital of Eastern Ontario.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.